EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C23H40O3 |
| Net Charge | 0 |
| Average Mass | 364.570 |
| Monoisotopic Mass | 364.29775 |
| SMILES | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCOC(CO)CO |
| InChI | InChI=1S/C23H40O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26-23(21-24)22-25/h6-7,9-10,12-13,15-16,23-25H,2-5,8,11,14,17-22H2,1H3/b7-6-,10-9-,13-12-,16-15- |
| InChIKey | CUJUUWXZAQHCNC-DOFZRALJSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. cannabinoid receptor agonist An agonist that binds to and activates cannabinoid receptors. cannabinoid receptor agonist An agonist that binds to and activates cannabinoid receptors. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 2-arachidonyl glyceryl ether (CHEBI:75913) is a 2-alkylglycerol (CHEBI:76581) |
| 2-arachidonyl glyceryl ether (CHEBI:75913) is a endocannabinoid (CHEBI:67197) |
| 2-arachidonyl glyceryl ether (CHEBI:75913) is a monoalkylglycerol (CHEBI:75883) |
| IUPAC Name |
|---|
| 2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraen-1-yloxy]propane-1,3-diol |
| Synonyms | Source |
|---|---|
| 2-(5Z,8Z,11Z,14Z-eicosatetraenyl)-sn-glycerol | LIPID MAPS |
| 2-AG ether | LIPID MAPS |
| 2-arachidonyl glycerol ether | ChEBI |
| (5Z,8Z,11Z,14Z)-icosatetraenyl-2-glyceryl ether | SUBMITTER |
| 5Z,8Z,11Z,14Z-eicosatetraen-2-glyceryl ether | LIPID MAPS |
| noladin ether | LIPID MAPS |
| UniProt Name | Source |
|---|---|
| 2-O-(5Z,8Z,11Z,14Z)-eicosatetraenylglycerol | UniProt |
| Manual Xrefs | Databases |
|---|---|
| 2-Arachidonyl_glyceryl_ether | Wikipedia |
| HMDB0013657 | HMDB |
| LMGL01010029 | LIPID MAPS |
| Registry Numbers | Sources |
|---|---|
| Reaxys:8798140 | Reaxys |
| CAS:222723-55-9 | HMDB |
| Citations |
|---|